Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025
Venus Concept (NASDAQ: VERO), a global medical aesthetic technology leader, has scheduled the release of its fourth quarter and fiscal year 2024 financial results for March 31, 2025, before market opening.
The company will host a conference call at 8:00 a.m. Eastern Time on the same day, featuring a management discussion and Q&A session. Interested participants can dial 877-407-2991 (201-389-0925 for international callers) using access code 13751985. A live webcast will be available on the company's investor relations website, with a two-week replay period available afterward.
Venus Concept (NASDAQ: VERO), leader globale nella tecnologia estetica medica, ha programmato la pubblicazione dei risultati finanziari per il quarto trimestre e l'anno fiscale 2024 per il 31 marzo 2025, prima dell'apertura del mercato.
L'azienda ospiterà una teleconferenza alle 8:00 a.m. Eastern Time lo stesso giorno, con una discussione da parte della direzione e una sessione di domande e risposte. I partecipanti interessati possono chiamare il numero 877-407-2991 (201-389-0925 per i chiamanti internazionali) utilizzando il codice di accesso 13751985. Una diretta web sarà disponibile sul sito delle relazioni con gli investitori dell'azienda, con un periodo di riproduzione di due settimane disponibile successivamente.
Venus Concept (NASDAQ: VERO), líder global en tecnología estética médica, ha programado la publicación de sus resultados financieros del cuarto trimestre y del año fiscal 2024 para el 31 de marzo de 2025, antes de la apertura del mercado.
La empresa llevará a cabo una conferencia telefónica a las 8:00 a.m. hora del Este el mismo día, que incluirá una discusión de la dirección y una sesión de preguntas y respuestas. Los participantes interesados pueden llamar al 877-407-2991 (201-389-0925 para llamadas internacionales) utilizando el código de acceso 13751985. Se dispondrá de una transmisión en vivo en el sitio web de relaciones con inversores de la empresa, con un período de repetición de dos semanas disponible después.
비너스 컨셉 (NASDAQ: VERO), 글로벌 의료 미용 기술의 선두주자는 2024 회계연도 4분기 재무 결과 발표를 2025년 3월 31일에 시장 개장 전에 예정하고 있습니다.
회사는 같은 날 동부 표준시 기준 오전 8:00에 경영진의 논의와 질의응답 세션을 포함한 컨퍼런스 콜을 개최할 것입니다. 관심 있는 참가자는 877-407-2991 (국제 전화는 201-389-0925)로 접속 코드 13751985를 사용하여 전화할 수 있습니다. 회사의 투자자 관계 웹사이트에서 생중계가 제공되며, 이후 2주간 재생 기간이 제공됩니다.
Venus Concept (NASDAQ: VERO), un leader mondial dans la technologie esthétique médicale, a prévu la publication de ses résultats financiers pour le quatrième trimestre et l'année fiscale 2024 pour le 31 mars 2025, avant l'ouverture du marché.
L'entreprise organisera une conférence téléphonique à 8h00, heure de l'Est le même jour, comprenant une discussion de la direction et une session de questions-réponses. Les participants intéressés peuvent composer le 877-407-2991 (201-389-0925 pour les appelants internationaux) en utilisant le code d'accès 13751985. Un webinaire en direct sera disponible sur le site des relations investisseurs de l'entreprise, avec une période de rediffusion de deux semaines par la suite.
Venus Concept (NASDAQ: VERO), ein globaler Marktführer in der medizinischen Ästhetik-Technologie, hat die Veröffentlichung seiner Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2024 für den 31. März 2025 vor Markteröffnung angesetzt.
Das Unternehmen wird am selben Tag um 8:00 Uhr Eastern Time eine Telefonkonferenz abhalten, die eine Diskussion der Geschäftsführung und eine Fragerunde umfasst. Interessierte Teilnehmer können die Nummer 877-407-2991 (201-389-0925 für internationale Anrufer) mit dem Zugangscode 13751985 wählen. Ein Live-Webcast wird auf der Investor-Relations-Website des Unternehmens verfügbar sein, mit einer zweiwöchigen Wiederholungsperiode danach.
- None.
- None.
TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2024 financial results will be released before the market opens on Monday, March 31, 2025.
Management will host a conference call at 8:00 a.m. Eastern Time on March 31, 2025 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13751985. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.
For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853 (201-612-7415 for international callers); access code 13751985. The webcast will be archived at ir.venusconcept.com.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 12 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.
FAQ
When will Venus Concept (VERO) release its Q4 and FY 2024 earnings?
How can investors join Venus Concept's (VERO) Q4 2024 earnings call?
Where can I find the replay of Venus Concept's (VERO) Q4 2024 earnings call?
What time is Venus Concept's (VERO) Q4 2024 earnings conference call?
